InMed Pharmaceuticals Inc.: 1 tracked 2026 layoff event(s), 0 workers counted, highest AI score 4.
AI score 4 (80% interval 3–4) · evidence grade D · US · Pharma / Chemicals
Stated reason: As previously reported, H.R. 5371, the “Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026” (the “Act”) in its current form and without further amendment, will have a material negative impact on BayMedica LLC (“BayMedica”), a wholly owned subsidiary of InMed Pharmaceuticals Inc. (the “Company”). Specifically, certain aspects of BayMedica’s …
Why 4: Plant, store or site closure · Drivers: contrary evidence −0.6, industry AI exposure +0.5, role AI exposure +0.1
Signals: attribution 0.0, primary 0.0, exec 0.0, role exposure 0.653, industry exposure 0.712, AI investment 0.0, contrary 0.4 · typical Health Care & Pharma roles (no roles named)
Headcount basis: not disclosed
Company AI financials (AI spending, revenue, earnings-call AI mentions) are coming soon to this page.
